Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 408 (ZNF408) is a 720-amino acid transcription factor belonging to the C2H2 zinc finger family, characterized by 10 tandem C2H2-type zinc finger motifs essential for DNA binding[1][2][4][5]. It also contains a predicted SET domain implicated in protein–protein interactions that regulate chromatin structure and gene expression[1]. ZNF408 localizes primarily to the cell nucleus and plays critical roles in retinal vasculature development, as supported by animal model studies[1][3]. Mutations in ZNF408 have been causally linked to familial exudative vitreoretinopathy (FEVR), an inherited retinal vascular disease, and to a lesser extent, retinitis pigmentosa 72. In affected individuals, specific missense mutations can cause mislocalization of the protein and dominant-negative effects impairing protein function[1][5]. ZNF408 is not currently a direct drug target but serves as a disease gene and genetic biomarker for clinical diagnosis of FEVR.
Not applicable; ZNF408 is a transcription factor rather than a conventional pharmacological target. Mutations in ZNF408 may act in a dominant-negative fashion, disrupting normal protein localization and function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 408 (ZNF408).